1
by Raman, Gowri
Published 2012
Agency for Healthcare Research and Quality
Subjects: ...Product Surveillance, Postmarketing...

2
by Trikalinos, Thomas A.
Published 2011
Agency for Healthcare Research and Quality

3
by Trikalinos, Thomas A.
Published 2011
Agency for Healthcare Research and Quality

4
by Balk, Ethan
Published 2012
Agency for Healthcare Research and Quality
... discussed by stakeholders (excluding product makers) on a secure Web site discussion board....

5
by Balk, Ethan
Published 2012
Agency for Healthcare Research and Quality
... discussed by stakeholders (excluding product makers) on a secure Web site discussion board....

8
by Rao, Madhumathi
Published 2012
Agency for Healthcare Research and Quality
... marrow and produce immunoglobulins that constitute the body's normal humoral immune response...

9
by Rao, Madhumathi
Published 2012
Agency for Healthcare Research and Quality
... marrow and produce immunoglobulins that constitute the body's normal humoral immune response...

10
by Dahabreh, Issa J.
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

11
by Dahabreh, Issa J.
Published 2012
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

12
by Lau, Joseph
Published 2012
Agency for Healthcare Research and Quality
... of this repository is to improve the quality and efficiency of producing systematic reviews, in order to inform...

13
by Shekelle, Paul G.
Published 2011
Agency for Healthcare Research and Quality

14
by Shekelle, Paul G.
Published 2011
Agency for Healthcare Research and Quality

15
by Lau, Joseph
Published 2012
Agency for Healthcare Research and Quality
... of this repository is to improve the quality and efficiency of producing systematic reviews, in order to inform...

16
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
AHRQ Technology Assessment Program
... that pharmacogenetic testing and the subsequent use of targeted therapies will add cost without producing clinically...

17
by Terasawa, Teruhiko, Dahabreh, Issa J., Castaldi, Peter J., Trikalinos, Thomas A.
Published 2010
AHRQ Technology Assessment Program
... that pharmacogenetic testing and the subsequent use of targeted therapies will add cost without producing clinically...

18
by Dahabreh, Issa J.
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

19
by Dahabreh, Issa J.
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

20
by Lau, Joseph
Published 2013
Agency for Healthcare Research and Quality (US)
.../RECOMMENDATIONS: This process engaged the EPCs in a productive, collaborative evaluation and response to the work...